Christopher Dvorak: Clinical Trials

2 trials sponsored by Christopher Dvorak, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 no longer available, 1 recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1

Follow Christopher Dvorak: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant
CliniMacs® - Graft Vs Host Disease, Graft-versus-host-disease
Not applicableRecruitingChristopher Dvorak902019-12-192026-04-13
Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
CD34+ enriched, T Cell Depleted donor stem cell product - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
No longer availableChristopher Dvorak2021-05-27

Conditions studied

Graft vs Host Disease (2)  ·  Bone Diseases (1)  ·  Bone Diseases, Developmental (1)  ·  Bone Marrow Diseases (1)  ·  Bone Marrow Failure Disorders (1)  ·  Cytopenia (1)  ·  Genetic Diseases, Inborn (1)  ·  Hematologic Diseases (1)  ·  Hemoglobinopathies (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)

Interventions

Bone Marrow Transplantation (1)

Countries

United States (2)

Top investigators

Christopher C Dvorak, MD (1)

Results publications

PMID 39042892